Test Price
2,800 AEDโ Home Collection Available
GPHN Gene Molybdenum Cofactor Deficiency Type C Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
ุชุญููู ุฌูู GPHN ูููุต ุงูุนุงู ู ุงูู ุณุงุนุฏ ููู ูููุจุฏูููู ู ู ุงูููุน C ูู ุงูุฅู ุงุฑุงุช | 2800 ุฏุฑูู | ู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู
- โ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- โ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy (8 AM โ 11 PM).
- โ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- โ Insurance: Direct Billing Verification via WhatsApp: +971 54 548 8731.
ูุถู ู ุชุญููู ุงูุฌูู GPHN ุจุชูููุฉ ุงูุชุณูุณู ุงูุฌููู ุงูู ุชูุฏู (NGS) ุชุดุฎูุตูุง ุฏููููุง ูููุต ุงูุนุงู ู ุงูู ุณุงุนุฏ ููู ูููุจุฏูููู ู ู ุงูููุน C ููู ู ุนุงููุฑ ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู 2026.
Clinical & Genetic Overview
The GPHN gene NGS test identifies pathogenic variants causing Molybdenum Cofactor Deficiency Type C (MOCOD type C), a rare, life-threatening neurometabolic disorder. This comprehensive sequencing detects single nucleotide variants, small indels, and copy number changes across the full coding region, enabling early diagnosis, family risk assessment, and targeted management in the UAE population. ููุดู ุงูุชุญููู ุนู ุงูุทูุฑุงุช ุงูู ุณุจุจุฉ ูููุต ุงูุนุงู ู ุงูู ุณุงุนุฏ ููู ูููุจุฏูููู ู ู ุงูููุน C ุจุฏูุฉ ูุงุฆูุฉ.
| Feature | Our GPHN NGS Test | Biochemical Enzyme Assay |
|---|---|---|
| Diagnostic Precision | Full gene sequencing (NGS) โ detects >99% of pathogenic variants | Indirect measurement of sulfite oxidase/xanthine dehydrogenase activity; may miss carrier status |
| Methodology | Next-Generation Sequencing with CNV analysis | Spectrophotometric / fluorometric enzyme assays |
| Turnaround Time | 3 โ 4 Weeks | 2 โ 4 Weeks |
| Clinical Utility | Absolute confirmation, family screening, prenatal/preimplantation options | Functional confirmation only; cannot identify carriers |
Physician Insight & Safety Protocol
"Genetic testing for Molybdenum Cofactor Deficiency Type C is a powerful diagnostic tool, but it must be interpreted alongside biochemical and clinical findings. A positive GPHN mutation confirms the diagnosis and allows precise genetic counselling, while a negative result does not exclude other inborn errors of metabolism. I urge all families to seek expert metabolic consultation before and after testing."
โ Dr. PRABHAKAR REDDY, DHA License: 61713011
โ Medication Warning: Do not discontinue any prescribed medication, including anticonvulsants or metabolic formulas, without first consulting your managing physician. Test results must inform, not replace, ongoing medical care.
Exclusion Criteria & Emergency Red Flags
- This test is not intended for asymptomatic general population screening without clinical suspicion of neurometabolic disease.
- Requires prior genetic counselling session (pedigree chart mandatory).
- Seek urgent emergency care if the patient develops: therapy-resistant seizures, encephalopathy, respiratory distress, or rapid neurological deteriorationโDO NOT wait for test results.
- Test cannot be performed on non-viable samples or those collected outside the approved cold-chain protocol.
Patient FAQ & Clinical Guidance
What does a positive GPHN NGS result mean for my childโs treatment?
A positive GPHN mutation confirms Molybdenum Cofactor Deficiency Type C, which guides urgent initiation of cyclic pyranopterin monophosphate (cPMP) therapy if eligible, and directs lifelong metabolic management under a specialist team. Your neonatologist will explain all actionable steps immediately upon receiving the validated report.
ู ุงุฐุง ุชุนูู ุงููุชูุฌุฉ ุงูุฅูุฌุงุจูุฉ ููุญุต ุฌูู GPHN ุจุงููุณุจุฉ ูุนุงุฆูุชูุ
ุฅุฐุง ูุงูุช ูุชูุฌุฉ ุงูุชุญููู ุฅูุฌุงุจูุฉุ ููุฐุง ูุคูุฏ ุชุดุฎูุต ููุต ุงูุนุงู ู ุงูู ุณุงุนุฏ ููู ูููุจุฏูููู ู ู ุงูููุน C ููุชูุญ ุงููุดู ุงูู ุจูุฑ ุนู ุญุงู ูู ุงูู ุฑุถ ูู ุงูุนุงุฆูุฉ ุนุจุฑ ุงูุงุฎุชุจุงุฑุงุช ุงูุฌูููุฉ ูููุงูุฏูู ูุงูุฃุดูุงุก. ูู ูู ููุงุณุชุดุงุฑู ุงููุฑุงุซู ุชูุธูู ุฌูุณุฉ ุชุฎุทูุท ุฃุณุฑู ูู ูุงูุดุฉ ุฎูุงุฑุงุช ุงูุฅูุฌุงุจ ุงูู ุณุชูุจููุฉ ูุงูููุงูุฉ.
Is home sample collection available for this genetic across the UAE?
Yes, our ISO-certified cold-chain home collection service operates daily from 8 AM to 11 PM, and a trained pediatric phlebotomist will collect the required blood or FTA card sample at your doorstep within 60 minutes of your confirmed appointment. This service covers all Emirates including Abu Dhabi, Dubai, Sharjah, and the Northern Regions.
UAE Healthcare Compliance
This service fully adheres to Federal Decree-Law No. 41 of 2024 (Article 87), the 2026 Clinical Decision Support (CDS) Law for Minors, and the UAE Personal Data Protection Law (PDPL). Facility License: 9834453. ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Genetic counselling is mandatory before sample collection; all data is anonymized and encrypted per local standards.
For appointments & insurance verification, contact WhatsApp: +971 54 548 8731
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians